NCT03158051

Brief Summary

This is a 5-year randomized controlled trial in two large healthcare systems (Madison and Milwaukee, WI) to evaluate MyHEART's (My Hypertension Education And Reaching Target) impact on blood pressure among 310 geographically and racially/ethnically diverse young adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
316

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 17, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

October 2, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2022

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2022

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

May 17, 2023

Completed
Last Updated

May 17, 2023

Status Verified

May 1, 2023

Enrollment Period

4.3 years

First QC Date

May 15, 2017

Results QC Date

February 6, 2023

Last Update Submit

May 15, 2023

Conditions

Keywords

HypertensionYoung AdultSelf-ManagementHealth coach

Outcome Measures

Primary Outcomes (4)

  • 24-hour Systolic Ambulatory Blood Pressure (mmHg)

    24-hour Systolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.

    baseline, 6 month, and 12 month follow-up

  • 24-hour Diastolic Ambulatory Blood Pressure (mmHg)

    24-hour Diastolic Ambulatory Blood Pressure measured at baseline, 6 months, and 12 months.

    baseline, 6 month, and 12 month follow-up

  • Clinic Systolic Blood Pressure (mmHg)

    Systolic Blood Pressure measured at baseline, 6 months, and 12 months.

    baseline, 6 month, and 12 month follow-up

  • Clinic Diastolic Blood Pressure (mmHg)

    Clinic Diastolic Blood Pressure measured at baseline, 6 months, and 12 months.

    baseline, 6 month, and 12 month follow-up

Secondary Outcomes (18)

  • Number of Participants That Achieve Hypertension Control at 6 Months

    up to 6 months

  • Sodium Intake as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

    baseline, 6 month, and 12 month follow-up

  • Number of Combined Fruit and Vegetable Servings as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

    baseline, 6 month, and 12 month follow-up

  • Ounces of Whole Grain as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

    baseline, 6 month, and 12 month follow-up

  • Saturated Fat as Assessed by the Automated Self-Administered 24-hour Dietary Assessment

    baseline, 6 month, and 12 month follow-up

  • +13 more secondary outcomes

Other Outcomes (4)

  • Health Coach Fidelity to the Study Intervention

    through completion of administering the study intervention, an average of 4 years

  • Adverse Events

    Through study completion, an average of 5 years

  • Serious Adverse Events

    Through study completion, an average of 5 years

  • +1 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Telephone health coaching, home blood pressure monitoring, individualized goal setting, and tailored educational materials

Behavioral: Home Blood Pressure MonitoringBehavioral: Telephone Health Coaching

Usual clinical care

NO INTERVENTION

Usual care arm participants will receive routine hypertension clinical care per their primary care provider.

Interventions

Intervention arm participants will receive a home blood pressure monitor, home blood pressure log, and training on accurate home monitoring. They will be asked to share their home blood pressure readings during health coach telephone calls.

Intervention

Intervention arm participants will receive a health coach phone call every 2 weeks for 6 months, for a total of 12 calls. During each call, the health coach will review and discuss home blood pressures and address barriers and concerns to hypertension management. During each telephone call, the coach will guide the participant on selecting health behavior goals. Intervention arm participants will also receive handouts about hypertension management during the study visits and after health coach calls.

Intervention

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Willing and capable of giving written informed consent
  • Willing to comply with all study procedures and be available for the duration of the study
  • Males and females ages 18-39 years old at the start of the study (inclusive)
  • A minimum of two hypertension ICD-10 coded visits with a provider (physician \[MD, DO\], physician assistant, nurse practitioner) on different dates in the last 24 months, with at least one code in the past 18 months
  • Medically homed at an IRB approved healthcare system

You may not qualify if:

  • History of medically determined Congestive Heart Failure
  • Unable to provide informed consent (i.e., activated healthcare power of attorney)
  • Unable or unwilling to travel to local clinic for research visits
  • Currently residing in a skilled nursing facility
  • Diagnosed with sickle cell anemia or cystic fibrosis
  • Diagnosed with stroke, myocardial infarction, and/or coronary artery revascularization in the past 2 years
  • Syncope while exercising or doing strenuous activity within past 12 months
  • Currently prescribed warfarin, novel oral anticoagulant, or insulin
  • Planned organ transplant or prior transplant in the past 5 years
  • Chemotherapy or radiation therapy within 6 the past months
  • Severely impaired hearing, vision, or speech, as determined by study staff responsible for enrollment
  • Current participation or planning to participate in another clinical trial in the next 12 months
  • Pregnant or planning to become pregnant in the next 12 months
  • Planning to leave the geographic area in the next 6 months
  • Health condition that will limit both increasing physical activity and changing diet
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Wisconsin School of Medicine & Public Health

Madison, Wisconsin, 53792, United States

Location

Aurora Health Care

Milwaukee, Wisconsin, 53233, United States

Location

Related Publications (2)

  • Johnson HM, Sullivan-Vedder L, Kim K, McBride PE, Smith MA, LaMantia JN, Fink JT, Knutson Sinaise MR, Zeller LM, Lauver DR. Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trial. Contemp Clin Trials. 2019 Mar;78:88-100. doi: 10.1016/j.cct.2019.01.010. Epub 2019 Jan 21.

    PMID: 30677485BACKGROUND
  • Hoppe KK, Smith M, Birstler J, Kim K, Sullivan-Vedder L, LaMantia JN, Knutson Sinaise MR, Swenson M, Fink J, Haggart R, McBride P, Lauver DR, Johnson HM. Effect of a Telephone Health Coaching Intervention on Hypertension Control in Young Adults: The MyHEART Randomized Clinical Trial. JAMA Netw Open. 2023 Feb 1;6(2):e2255618. doi: 10.1001/jamanetworkopen.2022.55618.

MeSH Terms

Conditions

HypertensionRisk Reduction Behavior

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesBehavior

Results Point of Contact

Title
Kara Hoppe, DO
Organization
University of Wisconsin School of Medicine and Public Health

Study Officials

  • Kara Hoppe, DO

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2017

First Posted

May 17, 2017

Study Start

October 2, 2017

Primary Completion

January 13, 2022

Study Completion

February 8, 2022

Last Updated

May 17, 2023

Results First Posted

May 17, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations